ARTG Entry

POTELIGEO

ARTG entry for POTELIGEO (mogamulizumab), ARTG 330232 — Product Information, dosage form, registration history. Compiled by arcimedes.

• Sponsor: Kyowa Kirin
• Active ingredient: mogamulizumab
• Therapeutic area: Oncology

TGA Public Summary — ARTG 330232